CMC Global celebrated a double win at the Asian Technology Excellence Awards 2024, for Automation in Aviation and Software in IT Services, reinforcing its innovation and Southeast Asia expansion, particularly in Singapore. 

HANOI, Vietnam, Oct. 9, 2024 /PRNewswire/ — CMC Global, a leading name in Vietnam’s tech industry, proudly announced its double win at the Asian Technology Excellence Awards 2024. The company received accolades for its excellence in Automation in Aviation and Software in IT Services, solidifying its position as a key technological innovator in the region.

These accolades highlight CMC Global’s dedication to driving technological breakthroughs and delivering transformative solutions across multiple industries. This achievement aligns with the company’s broader strategy of expanding its influence in the APAC region, with a strong focus on Singapore, the rapidly growing technology hub in Southeast Asia.

Singapore, with its advanced digital infrastructure and business-friendly environment, presents vast opportunities for technology providers like CMC Global. As a hub for innovation, CMC Global aims to leverage this potential by offering enhanced digital solutions across various sectors, including finance, healthcare, retail, and banking, driving digital transformation forward.

As part of its growth strategy, CMC Global aims to lead in Business Process Automation, focusing on Robotic Process Automation (RPA) and Low-Code platforms. The company plans to drive digital transformation by integrating RPA, AI, Cloud, and emerging technologies into its services.

In the near term, CMC Global will further advance towards Hyper Automation, broadening its capabilities beyond RPA and Low-Code by incorporating Artificial Intelligence (AI) and Machine Learning (ML). This comprehensive approach will enable clients to optimize their operations and unlock greater business value through intelligent automation, a critical factor for staying competitive in today’s fast-evolving digital economy.

Building on recent successes, CMC Global is set to launch the “Enable Your AI-X” initiative, which focuses on driving global innovation through AI. This initiative will help businesses streamline processes and create more efficient digital infrastructures.

By equipping clients with cutting-edge AI solutions, the AI-X initiative aligns with CMC Global’s vision to become a global tech leader by 2028, significantly contributing to its growth while supporting businesses in Southeast Asia on their digital transformation journeys.

As technology continues to reshape industries across the region, CMC Global’s expertise and innovative solutions are well-positioned to help businesses in Singapore and beyond realize their full potential.

For more details, visit https://cmcglobal.com.vn/.

For hi-res image of CMC Global, please click HERE

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/cmc-global-celebrates-dual-triumph-at-the-asian-technology-excellence-awards-2024-302272230.html

SOURCE CMC Global

XR Health announces a new U.S. patent for its Virtual and Augmented Reality Telecommunication Platforms, enabling real-time remote healthcare, personalized treatment, and multi-user collaboration in immersive virtual environments.

BOSTON and TEL AVIV, Ill., Oct. 9, 2024 /PRNewswire-PRWeb/ — XR Health, a leading innovator in immersive digital healthcare technology, proudly announces the issuance of a new U.S. utility patent (Patent No. US 12,067,324 B2) for its Virtual and Augmented Reality Telecommunication Platforms. This patent highlights XR Health’s commitment to advancing clinical treatment and patient evaluation through immersive virtual environments.

The patented technology enables real-time, multi-layered virtual and augmented reality experiences for medical treatment, rehabilitation, and training. By integrating biometric sensors and telecommunication capabilities, XR Health’s platform allows healthcare providers to track patient performance remotely and adjust treatments in real-time, providing personalized care regardless of location.

Key features of the patented platform include:

Real-time Patient Data Monitoring: Collects and transmits biometric and positional data to healthcare providers for real-time assessment.Multi-User Collaboration: Allows multiple users, including healthcare providers, patients, and trainees, to interact within a shared virtual environment.Dynamic Treatment Adjustments: Automatically adapts therapeutic activities based on patient performance metrics.Immersive Treatment Protocols: Uses VR/AR/MR overlays to guide patients through rehabilitation and assessment tasks.

The issuance of this patent further cements XR Health’s position as a leader in the Immersive health space, continuing to develop solutions that enhance accessibility and effectiveness in patient care.

For more information, visit https://www.xr.health or contact info@xr.health

Media Contact

Info, XRHealth, 1 8579906111, info@xr.health, https://www.xr.health/

View original content:https://www.prweb.com/releases/xr-health-secures-utility-patent-for-groundbreaking-virtual-and-augmented-reality-telecommunication-platforms-302271954.html

SOURCE XRHealth

WINDSOR, Conn., Oct. 10, 2024 /PRNewswire/ — SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that abrdn, the global investment company and asset manager, has extended its long-term transfer agency relationship with SS&C Global Investor and Distribution Solutions (GIDS) for its U.K., Luxembourg and Singapore fund ranges.

“We are pleased to continue our long-standing relationship with SS&C in the U.K. and Luxembourg while extending it into Singapore,” said Martin Kwiatkowski, COO Investments, abrdn. “As a leading global asset manager, abrdn is committed to providing the same high-quality experience to our clients, no matter where they are in the world or however they want to engage.”

SS&C provides transfer agency services for abrdn’s OEIC and Life funds. SS&C’s Luxembourg team supports abrdn across liquidity and Société d’investissement à Capital Variable (SICAVs) funds. abrdn also leverages SS&C GIDS for its U.S. funds. The latest contract includes enhanced servicing to provide responsiveness to investors in abrdn’s Luxembourg-domiciled funds. SS&C is partnering with abrdn to simplify client reporting, and enhance AML services to support their fund range. Additionally, SS&C is partnering with abrdn to enhance the services available through digital channels for our Singapore business.

“We are thrilled to extend our valued long-term relationship with abrdn to support abrdn’s local fund range in Singapore,” said Euan Mcleod, Head of SS&C GIDS, APAC. “This expansion further solidifies the strong partnership we already share, delivering an exceptional service to abrdn and their retail, corporate and institutional clients.”

About abrdn

abrdn is a global investment company that helps clients and customers plan, save and invest for the future. Our purpose is to enable our clients to be better investors. abrdn manages and administers £505.9bn of assets for clients (as of 30 June 2024).

About SS&C Technologies

SS&C is a global provider of services and software for the financial services and healthcare industries. Founded in 1986, SS&C is headquartered in Windsor, Connecticut, and has offices around the world. Some 20,000 financial services and healthcare organizations, from the world’s largest companies to small and mid-market firms, rely on SS&C for expertise, scale and technology.

Additional information about SS&C (Nasdaq: SSNC) is available at www.ssctech.com.

Follow SS&C on Twitter, LinkedIn and Facebook.

SOURCE SS&C